https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MS.jpg

Peripheral Vascular Devices Market Analysis, Size, Trends | Global | 2020-2026 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Africa, Middle East, North America, Asia-Pacific, Europe, Latin America
  • Pages: 845
  • Published Date: 7/24/2020
  • Type: MedSuite

By 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026.

Throughout this medical market research, we analyzed 113 peripheral vascular companies across more than 70 countries and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the Global Peripheral Vascular Devices market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Peripheral Vascular Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Peripheral Vascular Market Insights

In 2020, the global peripheral vascular market will be defined by the final outcomes of the guidelines made by the National Institute of Health and Care Excellence (NICE) in the United Kingdom. This organization released original draft guidelines in 2018 suggesting that endovascular aneurysm repair (EVAR) not be performed on pre-ruptured aneurysms. The largest market, stent grafts, is expected to be significantly impacted by the globally recognized health body’s final guidelines, and the decades-long trend towards EVAR might be reversed to open surgical repair.

Global Peripheral Vascular Market Size by Segment, 2016-2026

The Asia Pacific and Latin American markets are characterized by rapidly expanding healthcare systems and growth in local treatment rates. These regions have been noted for their moderate to low pricing (excluding Japan) and are expected to achieve the highest overall growth in the peripheral vascular market. Within all regions, the venous treatment market has been growing explosively, and separate analyses estimate that the market will represent approximately 25%-33% of the bare metal stent market value by the end of 2026. This massive increase in global procedures is also increasing the total introducer sheath, guidewire, and catheter markets.

In 2018, the release of the paclitaxel meta-analysis by Katsanos raised serious concerns about the late-mortality of drug-coated balloons (DCB) and drug-eluting stents (DES). Although the FDA released a statement in August 2019 stating that they were not able to identify a late-mortality signal caused by paclitaxel use in the peripheries, hesitancy about the use of these devices still remains. The overall market is expected to recover, but this event stopped the impressive double-digit growth that was seen prior to 2018.

Peripheral Vascular Market Share Insight

Global Peripheral Vascular Market Leading CompetitorsBy 2020, Medtronic was the leading competitor in the total peripheral vascular device market. The company derived its leading position from a strong showing in the high-value stent graft, DCB and atherectomy market segments. The company’s broad market share has also afforded it a tremendous competitive success through the ability to market and cross-sell supporting interventional devices.

W. L. Gore derives a majority of its revenue from the stent graft market and had a strong presence in the covered stent market. Revenue from this latter segment has experienced a substantial amount of growth in recent history, due to the increasing penetration of covered stents. W. L. Gore was also a global leader in the total stent graft market by 2020, capturing a notable portion of the total peripheral market from that segment alone

Boston Scientific, which recently acquired BTG plc., was able to capture the third-leading position in the peripheral vascular market. Following a string of other acquisitions, the company has been substantially growing its oncology and venous treatment portfolios.

Disease Overview

The global report on the Peripheral Vascular Devices market covers the following diseases and associated procedures:

  • Peripheral artery disease (PAD) market – Angioplasty, stenting, and aortic aneurysm repair were amongst the most common procedures performed to treat peripheral arterial disease (PAD) in 2019.
  • Endovascular aneurysm repair market – Surgical and stent-graft procedures comprise the total aortic aneurysm repair procedures contained within this report.
  • Atherosclerosis market – Bypass grafting, stent placement, and atherectomy procedures are among the top treatments discussed in this market study.
  • Deep Vein Thrombosis (DVT) market – Deep vein thrombosis is treated either through a series of medications, surgery, compression stockings, or by inferior vena cava filters. The global report contains an in-depth qualitative analysis of the disease.
  • Pulmonary Embolism market  – The report provides a global qualitative analysis of the disease and recent trends of its treatment.

Report Regional Coverage

Throughout this research series, iData Research has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Segments Covered

  • Procedure Volumes for Peripheral Vascular DevicesMedPro – The complete procedural analysis for each of the regions covered in the report, which includes Peripheral Vascular Stenting, PTA Balloon, Drug-Coated Balloon, Atherectomy,  Stent Graft, Surgical Graft,  CTO Device, Vascular Closure, Peripheral IVUS, and Intravascular Lithotripsy procedures.
  • Peripheral Vascular Stent Market – MedCore – This market is comprised of the markets for Bare-Metal Stents, Covered Stent, and Drug-Eluting Stents.
  • PTA Balloon Catheter Market – MedCore – The chapter provides an in-depth analysis of the PTA Balloon Catheter market.
  • Drug-Coated Balloon Market – MedCore – The in-depth analysis of the DCB market.
  • Atherectomy Disposables Market – MedCore – The chapter provides a comprehensive analysis of the Atherectomy market.
  • CTO Device Market – MedCore – The in-depth analysis of the CTO Device market across the globe.
  • Stent Graft Market – MedCore – The market is further broken down to AAA, TAA, and FAA Stent Grafts.
  • Surgical Graft Market – MedCore – The chapter takes a closer look at the Lower Limb, Aorta Repair, and Extra-Anatomical Bypass Surgical Grafts.
  • Diagnostic & Interventional Guidewire Market – MedCore – The market consists of the segments for Standard and Hydrophilic Guidewires.
  • Diagnostic & Interventional Catheter Market – MedCore – The market is further broken down into segments, such as Diagnostic and Interventional Catheter segments.
  • Introducer Sheath Market – MedCore – The comprehensive analysis of the Global Introducer Sheath Market.
  • Vascular Closure Device Market – MedCore – The market is further broken down into the Non-invasive and Invasive closure devices.
  • Peripheral IVUS Catheter Market – MedCore – The chapter takes a closer look at the Global Peripheral IVUS Catheter Market.
  • Intravascular Lithotripsy Market – MedCore – The in-depth analysis of the newly emerging Intravascular Lithotripsy Market.

Detailed Market Segmentation

Global Peripheral Vascular Market Segmentation - 1
Global Peripheral Vascular Market Segmentation - 2
Global Peripheral Vascular Market Segmentation - 3

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

Table of Contents for Global Peripheral Vascular Report Suite

TABLE OF CONTENTS I
LIST OF FIGURES XX
LIST OF CHARTS XLII
EXECUTIVE SUMMARY 1
GLOBAL PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
MARKETS INCLUDED 11
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 17
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis 23
Step 7: Identify Strategic Opportunities 25
Step 8: Final Review and Market Release 26
Step 9: Customer Feedback and Market Monitoring 27

DISEASE OVERVIEW

2.1 BASIC ANATOMY 28
2.2 DISEASE TREATMENTS & DIAGNOSTICS 29
2.2.1 Aortic Aneurysms 29
2.2.2 Atherosclerosis 30
2.2.3 Peripheral Arterial Disease (PAD) 31
2.2.4 Deep Vein Thrombosis (DVT) 32
2.2.5 Pulmonary Embolism (PE) 33
2.3 PATIENT DEMOGRAPHICS 35
2.3.1 Aortic Aneurysms 35
2.3.2 Atherosclerosis 35
2.3.3 Peripheral Arterial Disease (PAD) 35
2.3.4 Deep Vein Thrombosis (DVT) 36
2.3.5 Pulmonary Embolism (PE) 36

PRODUCT ASSESSMENT

3.1 INTRODUCTION 38
3.2 PRODUCT PORTFOLIOS 38
3.2.1 Peripheral Vascular Stent 38
3.2.2 Venous Stent 41
3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon 42
3.2.4 Drug-Coated Balloon 46
3.2.5 Atherectomy Device 48
3.2.6 Chronic Total Occlusion (CTO) Device 50
3.2.7 Intravascular Lithotripsy 52
3.2.8 Surgical Graft 53
3.2.9 Stent Graft 56
3.2.10 Embolic Protection Device 58
3.2.11 Peripheral Thrombus Management Device 60
3.2.12 Inferior Vena Cava Filter 63
3.2.13 Carotid Shunt 64
3.2.14 Diagnostic and Interventional Catheters 65
3.2.15 Diagnostic and Interventional Guidewire 68
3.2.16 Introducer Sheath 72
3.2.17 Vascular Closure Device (VCD) 76
3.2.18 Transcatheter Embolization Device 78
3.2.19 Peripheral IVUS Catheter 81
3.3 REGULATORY ISSUES AND RECALLS 82
3.4 CLINICAL TRIALS 116
3.4.1 Abbott 116
3.4.1.1 Peripheral Vascular Stent 116
3.4.1.2 Other Peripheral Vascular Related Studies 119
3.4.2 B. Braun 120
3.4.2.1 Diagnostic and Interventional Catheters 120
3.4.2.2 Peripheral Vascular Stent 120
3.4.3 Boston Scientific 121
3.4.3.1 Atherectomy Devices 121
3.4.3.2 Drug-Coated Balloons 122
3.4.3.3 Peripheral Vascular Stents 124
3.4.3.4 Other Peripheral Vascular Related Studies 125
3.4.3.5 Venous Stents 125
3.4.4 C.R. Bard (BD) 126
3.4.4.1 Diagnostic and Interventional Catheters 126
3.4.4.2 Drug-Coated Balloons 126
3.4.4.3 Venous Stents 128
3.4.4.4 Other Peripheral Vascular Related Studies 129
3.4.5 Cardinal Health 130
3.4.5.1 Other Peripheral Vascular Related Studies 130
3.4.6 Cook Medical 131
3.4.6.1 Drug-Eluting Stents 131
3.4.6.2 Inferior Vena Cava Filters 133
3.4.6.3 Peripheral Vascular Stents 133
3.4.6.4 Venous Stents 134
3.4.7 Cordis (Cardinal Health) 135
3.4.7.1 Peripheral Vascular Stents 135
3.4.8 Medtronic 136
3.4.8.1 Atherectomy Devices 136
3.4.8.2 Drug-Coated Balloons 137
3.4.8.3 Other Peripheral Vascular Related Studies 143
3.4.10 Shockwave Medical, Inc. 151
3.4.10.1 Lithoplasty System 151
3.4.11 Surmodics 152
3.4.11.1 Drug-Coated Balloons 152
3.4.12 Terumo 153
3.4.12.1 Drug-Coated Balloons 153
3.4.12.2 Peripheral Vascular Stents 153
3.4.13 W.L. Gore 154
3.4.13.1 Peripheral Vascular Stents 154
3.4.13.2 Stent Grafts 155
3.4.13.3 Expandable Balloons 156
3.4.14 Other Companies 157
3.4.14.1 Carotid Shunt / Endarterectomy 157
3.4.14.2 Drug-Coated Balloons 158
3.4.14.3 Peripheral Vascular Stents 162
3.4.14.4 Other Peripheral Vascular Related Studies 165

GLOBAL PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

4.1 INTRODUCTION 166
4.1.1 Atherosclerosis 166
4.1.2 Peripheral Arterial Disease (PAD) 167
4.2 MARKET OVERVIEW 168
4.3 TREND ANALYSIS BY REGION 174
4.3.1 Global Trends 174
4.3.2 North America 175
4.3.3 Latin America 175
4.3.4 Western Europe 176
4.3.5 Central and Eastern Europe 176
4.3.6 Middle East 176
4.3.7 Africa 177
4.3.8 Asia-Pacific 178
4.4 DRIVERS AND LIMITERS 182
4.4.1 Market Drivers 182
4.4.2 Market Limiters 183
4.5 COMPETITIVE MARKET SHARE ANALYSIS 186
4.6 MERGERS AND ACQUISITIONS 192
4.7 COMPANY PROFILES 197
4.7.1 Abbott 197
4.7.2 Becton Dickinson (BD) 198
4.7.3 Boston Scientific 199
4.7.4 Cardinal Health 200
4.7.4.1 Cordis (Cardinal Health) 200
4.7.5 Cook Medical 201
4.7.6 Maquet 202
4.7.7 Medtronic 203
4.7.8 Teleflex 205
4.7.9 Terumo Interventional System (TIS) 206
4.7.10 W.L. Gore 207
4.8 SWOT ANALYSIS 208
4.8.1 Abbott 209
4.8.2 B. Braun 210
4.8.3 Boston Scientific 211
4.8.4 BD 212
4.8.5 Cardinal Health 213
4.8.6 Cook Medical 214
4.8.7 Integra Lifesciences 215
4.8.8 Maquet 216
4.8.9 Medtronic 217
4.8.10 Merit Medical 218
4.8.11 Phillips 219
4.8.12 Teleflex 220
4.8.13 Terumo 221
4.8.14 W.L. Gore 222

PROCEDURE NUMBERS

5.1 INTRODUCTION 223
5.2 PROCEDURES 227
5.2.1 Global Procedures 232
5.2.1.1 Bare Metal Stent Procedures by Indication 235
5.2.1.2 Stent Graft Procedures by Indication 237
5.2.1.3 Surgical Graft Procedures by Indication 239
5.2.2 North America Procedures 241
5.2.2.1 Bare-Metal Stent Procedures by Indication 244
5.2.2.2 Stent Graft Procedures by Indication 246
5.2.2.3 Surgical Graft Procedures by Indication 248
5.2.3 Latin America Procedures 250
5.2.3.1 Bare-Metal Stent Procedures by Indication 253
5.2.3.2 Stent Graft Procedures by Indication 255
5.2.3.3 Surgical Graft Procedures by Indication 257
5.2.4 Western Europe Procedures 259
5.2.4.1 Bare-Metal Stent Procedures 262
5.2.4.2 Stent Graft Procedures by Indication 264
5.2.4.3 Surgical Graft Procedures by Indication 266
5.2.5 Central & Eastern Europe Procedures 268
5.2.5.1 Bare-Metal Stent Procedures by Indication 271
5.2.5.2 Stent Graft Procedures by Indication 273
5.2.5.3 Surgical Graft Procedures by Indication 275
5.2.6 Middle East Procedures 277
5.2.6.1 Bare-Metal Stent Procedures by Indication 280
5.2.6.2 Stent Graft Procedures by Indication 282
5.2.6.3 Surgical Procedures by Indication 284
5.2.7 Africa Procedures 286
5.2.7.1 Bare-Metal Stent Procedures by Indication 289
5.2.7.2 Stent Graft Procedures by Indication 291
5.2.7.3 Surgical Graft Procedures by Indication 293
5.2.8 Asia-Pacific Procedures 295
5.2.8.1 Bare-Metal Stent Procedures by Indication 298
5.2.8.2 Stent Graft Procedures by Indication 300
5.2.8.3 Surgical Graft Procedures by Indication 302

NORTH AMERICA MARKET

6.1 INTRODUCTION 304
6.1.1 Countries Included 305
6.2 MARKET OVERVIEW 306
6.3 MARKET ANALYSIS AND FORECAST 313
6.3.1 Peripheral Vascular Stent Market 313
6.3.1.1 Market Overview 313
6.3.1.2 Total Peripheral Vascular Stent Market 316
6.3.1.2.1 Total Bare-Metal Stent Market 318
6.3.1.2.2 Covered Stent Market 325
6.3.1.2.3 Drug-Eluting Stent Market 326
6.3.2 PTA Balloon Catheter Market 328
6.3.3 Drug-Coated Balloon Market 331
6.3.4 Atherectomy Disposables Market 334
6.3.5 CTO Device Market 337
6.3.6 Stent Graft Market 339
6.3.6.1 Market Overview 339
6.3.6.2 Total Stent Graft Market 342
6.3.7 Surgical Graft Market 346
6.3.7.1 Market Overview 346
6.3.7.2 Total Surgical Graft Market 349
6.3.7.2.1 Total Aorta Repair Surgical Graft Market 350
6.3.7.2.2 Lower Limb Surgical Graft Market 353
6.3.7.2.3 Extra-Anatomical Surgical Graft Market 354
6.3.8 Diagnostic & Interventional Guidewire Market 355
6.3.8.1 Market Overview 355
6.3.8.2 Total Diagnostic & Interventional Guidewire Market 358
6.3.8.2.1 Standard Guidewire Market 359
6.3.8.2.2 Hydrophilic Guidewire Market 360
6.3.9 Diagnostic & Interventional Catheter Market 361
6.3.9.1 Market Overview 361
6.3.9.2 Total Diagnostic & Interventional Catheter Market 364
6.3.9.2.1 Diagnostic Catheter Market 365
6.3.9.2.2 Interventional Catheter Market 366
6.3.10 Introducer Sheath Market 367
6.3.11 Vascular Closure Device Market 370
6.3.11.1 Market Overview 370
6.3.11.2 Total VCD Market 373
6.3.11.2.1 Invasive VCD Market 374
6.3.11.2.2 Non-Invasive VCD Market 377
6.3.12 Peripheral IVUS Catheter Market 378

LATIN AMERICA MARKET

7.1 INTRODUCTION 381
7.1.1 Countries Included 381
7.2 MARKET OVERVIEW 383
7.3 MARKET ANALYSIS AND FORECAST 389
7.3.1 Peripheral Vascular Stent Market 389
7.3.1.1 Market Overview 389
7.3.1.2 Total Peripheral Vascular Stent Market 392
7.3.1.2.1 Total Bare-Metal Stent Market 394
7.3.1.2.2 Covered Stent Market 401
7.3.1.2.3 Drug-Eluting Stent Market 402
7.3.2 PTA Balloon Catheter Market 404
7.3.3 Drug-Coated Balloon Market 407
7.3.4 Atherectomy Disposables Market 410
7.3.5 CTO Device Market 412
7.3.6 Stent Graft Market 414
7.3.6.1 Market Overview 414
7.3.6.2 Total Stent Graft Market 417
7.3.6.2.1 AAA Stent Graft Market 418
7.3.6.2.2 TAA Stent Graft Market 419
7.3.6.2.3 FAA Stent Graft Market 420
7.3.7 Surgical Graft Market 421
7.3.7.1 Market Overview 421
7.3.7.2 Total Surgical Graft Market 424
7.3.7.2.1 Total Aorta Repair Surgical Graft Market 425
7.3.7.2.2 Lower Limb Surgical Graft Market 428
7.3.7.2.3 Extra-Anatomical Surgical Graft Market 429
7.3.8 Diagnostic & Interventional Guidewire Market 430
7.3.8.1 Market Overview 430
7.3.8.2 Total Diagnostic & Interventional Guidewire Market 433
7.3.8.2.1 Standard Guidewire Market 434
7.3.8.2.2 Hydrophilic Guidewire Market 435
7.3.9 Diagnostic & Interventional Catheter Market 436
7.3.9.1 Market Overview 436
7.3.9.2 Total Diagnostic & Interventional Catheter Market 439
7.3.9.2.1 Diagnostic Catheter Market 440
7.3.9.2.2 Interventional Catheter Market 441
7.3.10 Introducer Sheath Market 442
7.3.11 Vascular Closure Device Market 445
7.3.11.1 Market Overview 445
7.3.11.2 Total VCD Market 448
7.3.11.2.1 Invasive VCD Market 449
7.3.11.2.2 Non-Invasive VCD Market 452
7.3.12 Peripheral IVUS Catheter Market 453

WESTERN EUROPE MARKET

8.1 INTRODUCTION 456
8.1.1 Countries Included 457
8.2 MARKET OVERVIEW 458
8.3 MARKET ANALYSIS AND FORECAST 465
8.3.1 Peripheral Vascular Stent Market 465
8.3.1.1 Market Overview 465
8.3.1.2 Total Peripheral Vascular Stent Market 468
8.3.1.2.1 Total Bare-Metal Stent Market 469
8.3.1.2.2 Covered Stent Market 476
8.3.1.2.3 Drug-Eluting Stent Market 477
8.3.2 PTA Balloon Catheter Market 479
8.3.3 Drug-Coated Balloon Market 482
8.3.4 Atherectomy Disposables Market 485
8.3.5 CTO Device Market 487
8.3.6 Stent Graft Market 489
8.3.6.1 Market Overview 489
8.3.6.2 Total Stent Graft Market 492
8.3.6.2.1 AAA Stent Graft Market 493
8.3.6.2.2 TAA Stent Graft Market 494
8.3.6.2.3 FAA Stent Graft Market 495
8.3.7 Surgical Graft Market 496
8.3.7.1 Market Overview 496
8.3.7.2 Total Surgical Graft Market 499
8.3.7.2.1 Total Aorta Repair Surgical Graft Market 500
8.3.7.2.2 Lower Limb Surgical Graft Market 503
8.3.7.2.3 Extra-Anatomical Surgical Graft Market 504
8.3.8 Diagnostic & Interventional Guidewire Market 505
8.3.8.1 Market Overview 505
8.3.8.2 Total Diagnostic & Interventional Guidewire Market 508
8.3.8.2.1 Standard Guidewire Market 509
8.3.8.2.2 Hydrophilic Guidewire Market 510
8.3.9 Diagnostic & Interventional Catheter Market 511
8.3.9.1 Market Overview 511
8.3.9.2 Total Diagnostic & Interventional Catheter Market 513
8.3.9.2.1 Diagnostic Catheter Market 514
8.3.9.2.2 Interventional Catheter Market 515
8.3.10 Introducer Sheath Market 516
8.3.11 Vascular Closure Device Market 519
8.3.11.1 Market Overview 519
8.3.11.2 Total VCD Market 522
8.3.11.2.1 Invasive VCD Market 523
8.3.11.2.2 Non-Invasive VCD Market 526
8.3.12 Peripheral IVUS Catheter Market 527

CENTRAL & EASTERN EUROPE MARKET

9.1 INTRODUCTION 530
9.1.1 Countries Included 531
9.2 MARKET OVERVIEW 532
9.3 MARKET ANALYSIS AND FORECAST 539
9.3.1 Peripheral Vascular Stent Market 539
9.3.1.1 Market Overview 539
9.3.1.2 Total Peripheral Vascular Stent Market 542
9.3.1.2.1 Total Bare-Metal Stent Market 543
9.3.1.2.2 Covered Stent Market 550
9.3.1.2.3 Drug-Eluting Stent Market 551
9.3.2 PTA Balloon Catheter Market 553
9.3.3 Drug-Coated Balloon Market 556
9.3.4 Atherectomy Disposables Market 559
9.3.5 CTO Device Market 561
9.3.6 Stent Graft Market 563
9.3.6.1 Market Overview 563
9.3.6.2 Total Stent Graft Market 566
9.3.6.2.1 AAA Stent Graft Market 567
9.3.6.2.2 TAA Stent Graft Market 568
9.3.6.2.3 FAA Stent Graft Market 569
9.3.7 Surgical Graft Market 570
9.3.7.1 Market Overview 570
9.3.7.2 Total Surgical Graft Market 573
9.3.7.2.1 Total Aorta Repair Surgical Graft Market 574
9.3.7.2.2 Lower Limb Surgical Graft Market 577
9.3.7.2.3 Extra-Anatomical Surgical Graft Market 578
9.3.8 Diagnostic & Interventional Guidewire Market 579
9.3.8.1 Market Overview 579
9.3.8.2 Total Diagnostic & Interventional Guidewire Market 582
9.3.8.2.1 Standard Guidewire Market 583
9.3.8.2.2 Hydrophilic Guidewire Market 584
9.3.9 Diagnostic & Interventional Catheter Market 585
9.3.9.1 Market Overview 585
9.3.9.2 Total Diagnostic & Interventional Catheter Market 587
9.3.9.2.1 Diagnostic Catheter Market 588
9.3.9.2.2 Interventional Catheter Market 589
9.3.10 Introducer Sheath Market 590
9.3.11 Vascular Closure Device Market 593
9.3.11.1 Market Overview 593
9.3.11.2 Total VCD Market 596
9.3.11.2.1 Invasive VCD Market 597
9.3.11.2.2 Non-Invasive VCD Market 600
9.3.12 Peripheral IVUS Catheter Market 601

MIDDLE EAST MARKET

10.1 INTRODUCTION 604
10.1.1 Countries Included 605
10.2 MARKET OVERVIEW 606
10.3 MARKET ANALYSIS AND FORECAST 613
10.3.1 Peripheral Vascular Stent Market 613
10.3.1.1 Market Overview 613
10.3.1.2 Total Peripheral Vascular Stent Market 616
10.3.1.2.1 Total Bare-Metal Stent Market 618
10.3.1.2.2 Covered Stent Market 625
10.3.1.2.3 Drug-Eluting Stent Market 626
10.3.2 PTA Balloon Catheter Market 628
10.3.3 Drug-Coated Balloon Market 631
10.3.4 Atherectomy Disposables Market 634
10.3.5 CTO Device Market 636
10.3.6 Stent Graft Market 638
10.3.6.1 Market Overview 638
10.3.6.2 Total Stent Graft Market 641
10.3.6.2.1 AAA Stent Graft Market 642
10.3.6.2.2 TAA Stent Graft Market 643
10.3.6.2.3 FAA Stent Graft Market 644
10.3.7 Surgical Graft Market 645
10.3.7.1 Market Overview 645
10.3.7.2 Total Surgical Graft Market 648
10.3.7.2.1 Total Aorta Repair Surgical Graft Market 649
10.3.7.2.2 Lower Limb Surgical Graft Market 652
10.3.7.2.3 Extra-Anatomical Surgical Graft Market 653
10.3.8 Diagnostic & Interventional Guidewire Market 654
10.3.8.1 Market Overview 654
10.3.8.2 Total Diagnostic & Interventional Guidewire Market 657
10.3.8.2.1 Standard Guidewire Market 658
10.3.8.2.2 Hydrophilic Guidewire Market 659
10.3.9 Diagnostic & Interventional Catheter Market 660
10.3.9.1 Market Overview 660
10.3.9.2 Total Diagnostic & Interventional Catheter Market 663
10.3.9.2.1 Diagnostic Catheter Market 664
10.3.9.2.2 Interventional Catheter Market 665
10.3.10 Introducer Sheath Market 666
10.3.11 Vascular Closure Device Market 669
10.3.11.1 Market Overview 669
10.3.11.2 Total VCD Market 672
10.3.11.2.1 Invasive VCD Market 673
10.3.11.2.2 Non-Invasive VCD Market 676
10.3.12 Peripheral IVUS Catheter Market 677

AFRICA MARKET

11.1 INTRODUCTION 680
11.1.1 Countries Included 681
11.2 MARKET OVERVIEW 682
11.3 MARKET ANALYSIS AND FORECAST 688
11.3.1 Peripheral Vascular Stent Market 688
11.3.1.1 Market Overview 688
11.3.1.2 Total Peripheral Vascular Stent Market 691
11.3.1.2.1 Total Bare-Metal Stent Market 693
11.3.1.2.2 Covered Stent Market 700
11.3.1.2.3 Drug-Eluting Stent Market 701
11.3.2 PTA Balloon Catheter Market 703
11.3.3 Drug-Coated Balloon Market 706
11.3.4 Atherectomy Disposables Market 709
11.3.5 CTO Device Market 711
11.3.6 Stent Graft Market 713
11.3.6.1 Market Overview 713
11.3.6.2 Total Stent Graft Market 716
11.3.6.2.1 AAA Stent Graft Market 717
11.3.6.2.2 TAA Stent Graft Market 718
11.3.6.2.3 FAA Stent Graft Market 719
11.3.7 Surgical Graft Market 720
11.3.7.1 Market Overview 720
11.3.7.2 Total Surgical Graft Market 723
11.3.7.2.1 Total Aorta Repair Surgical Graft Market 724
11.3.7.2.2 Lower Limb Surgical Graft Market 727
11.3.7.2.3 Extra-Anatomical Surgical Graft Market 728
11.3.8 Diagnostic & Interventional Guidewire Market 729
11.3.8.1 Market Overview 729
11.3.8.2 Total Diagnostic & Interventional Guidewire Market 732
11.3.8.2.1 Standard Guidewire Market 733
11.3.8.2.2 Hydrophilic Guidewire Market 734
11.3.9 Diagnostic & Interventional Catheter Market 735
11.3.9.1 Market Overview 735
11.3.9.2 Total Diagnostic & Interventional Catheter Market 738
11.3.9.2.1 Diagnostic Catheter Market 739
11.3.9.2.2 Interventional Catheter Market 740
11.3.10 Introducer Sheath Market 741
11.3.11 Vascular Closure Device Market 743
11.3.11.1 Market Overview 743
11.3.11.2 Total VCD Market 746
11.3.11.2.1 Invasive VCD Market 747
11.3.11.2.2 Non-Invasive VCD Market 750
11.3.12 Peripheral IVUS Catheter Market 751

ASIA-PACIFIC MARKET

12.1 INTRODUCTION 753
12.1.1 Countries Included 754
12.2 MARKET OVERVIEW 755
12.3 MARKET ANALYSIS AND FORECAST 761
12.3.1 Peripheral Vascular Stent Market 761
12.3.1.1 Market Overview 761
12.3.1.2 Total Peripheral Vascular Stent Market 764
12.3.1.2.1 Total Bare-Metal Stent Market 766
12.3.1.2.2 Covered Stent Market 773
12.3.1.2.3 Drug-Eluting Stent Market 774
12.3.2 PTA Balloon Catheter Market 776
12.3.3 Drug-Coated Balloon Market 779
12.3.4 Atherectomy Disposables Market 782
12.3.5 CTO Device Market 784
12.3.6 Stent Graft Market 786
12.3.6.1 Market Overview 786
12.3.6.2 Total Stent Graft Market 789
12.3.6.2.1 AAA Stent Graft Market 790
12.3.6.2.2 TAA Stent Graft Market 791
12.3.6.2.3 FAA Stent Graft Market 792
12.3.7 Surgical Graft Market 793
12.3.7.1 Market Overview 793
12.3.7.2 Total Surgical Graft Market 796
12.3.7.2.1 Total Aorta Repair Surgical Graft Market 797
12.3.7.2.2 Lower Limb Surgical Graft Market 800
12.3.7.2.3 Extra-Anatomical Surgical Graft Market 801
12.3.8 Diagnostic & Interventional Guidewire Market 802
12.3.8.1 Market Overview 802
12.3.8.2 Total Diagnostic & Interventional Guidewire Market 804
12.3.8.2.1 Standard Guidewire Market 805
12.3.8.2.2 Hydrophilic Guidewire Market 806
12.3.9 Diagnostic & Interventional Catheter Market 807
12.3.9.1 Market Overview 807
12.3.9.2 Total Diagnostic & Interventional Catheter Market 810
12.3.9.2.1 Diagnostic Catheter Market 811
12.3.9.2.2 Interventional Catheter Market 812
12.3.10 Introducer Sheath Market 813
12.3.11 Vascular Closure Device Market 816
12.3.11.1 Market Overview 816
12.3.11.2 Total VCD Market 819
12.3.11.2.1 Invasive VCD Market 820
12.3.11.2.2 Non-Invasive VCD Market 823
12.3.12 Peripheral IVUS Catheter Market 824

APPENDIX: GLOBAL LITHOTRIPSY MARKET

13.1 INTRODUCTION 827
13.2 PROCEDURES 829
13.2.1 Global Procedures 830
13.3 MARKET OVERVIEW 831
13.4 MARKET ANALYSIS AND FORECAST 836
13.4.1 Global Lithotripsy Market 836
13.4.1.1 U.S. Lithotripsy Market 838
13.4.1.2 Western Europe Lithotripsy Market 840
13.4.1.3 Rest of the World Lithotripsy Market 842

ABBREVIATIONS

The Peripheral Vascular Devices Market Report Suite| Global | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Aachen Resonance GmbH.
  • Abbott Vascular
  • Acandis GmbH
  • ACIST Medical
  • Acrostak
  • Advanced Vascular Dynamics
  • Affluent Medical
  • ALN Implants Chirurgicaux
  • Alucent Medical
  • Amnis Therapeutics
  • Angiodynamics
  • Argon Medical
  • ArtVentive
  • Asahi Intecc
  • AV Medical
  • Avimedica
  • Avinger
  • B. Braun
  • Baylis Medical
  • Bentley
  • BiO2
  • Biotronik
  • Biovic
  • Blockade Medical
  • Boston Scientific
  • C. R. Bard
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cardiva
  • Celenova Biosciences Inc.
  • CME
  • Concordance Healthcare
  • Consolidated Service Center
  • Contego Medical
  • Control Medical Technology
  • Cook Medical
  • Creagh Medical
  • DePuy Synthes
  • Direct Access Medical
  • Edwards LifeSciences
  • Endocor
  • Endocross
  • Endologix
  • Endospan
  • Inari Medical
  • Infraredx
  • Innoventions
  • InSeal Medical
  • Integra LifeSciences
  • Invamed
  • Jotec (CryoLife)
  • Kaneka Medical
  • LeMaitre Vascular
  • Lepu Medical Technology
  • Lucas Medical
  • Maquet
  • Medico's Hirata
  • Medline
  • Medtronic
  • Meril Life Sciences
  • Merit Medical Systems
  • Mermaid Medical
  • Micro Medical Solutions
  • MicroPort
  • Morris Innovative Inc.
  • Nantec Medical Ltd.
  • Neovasc Inc.
  • Nipro
  • Nitiloop
  • Nordion
  • NuCryo Vascular
  • Optimed
  • OptiMed GmbH
  • Oscor
  • Oscor Inc.
  • Penumbra
  • Pfizer
  • PFM Medical
  • Philips
  • plus medica
  • PQ Bypass
  • PQ Crossing Device
  • Provisio Medical
  • Ra Medical
  • Radius Medical
  • Rafael Medical Technologies
  • Reflow Medical
  • REVA Medical
  • Rex Medical
  • Roxwood Medical
  • Scitech Medical
  • Shockwave Medical
  • Silk Road Medical
  • Sirtex Medical
  • SoundBite Medical Solutions
  • Straub Medical
  • Surmodics
  • Teleflex Medical
  • Terumo
  • Theragenics/Galt
  • Tokai Medical Products
  • Tricol Biomedical
  • TriReme Medical
  • TZ Medical
  • Varian Medical Systems
  • Vascular Flow Technologies
  • Vascular Graft Solutions
  • Vascular Solutions
  • Vascular-Flow Technologies
  • Vasorum
  • Vivasure Medical
  • W. L. Gore
  • Walk Vascular

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology